About
PBD Biotech develops phage-based diagnostic tests (Actiphage) that detect Mycobacterium species responsible for tuberculosis in blood samples from humans and animals. Their proprietary technology is used for rapid detection of TB to support livestock screening, reduce agricultural productivity losses, and improve human TB screening and drug management.
Explore PBD Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.